- Home
- EFX vs VTR Comparison
EFX vs VTR Comparison
Compare EFX & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFX
- VTR
- Stock Information
- Founded
- EFX 1899
- VTR 1983
- Country
- EFX United States
- VTR United States
- Employees
- EFX N/A
- VTR N/A
- Industry
- EFX Finance: Consumer Services
- VTR Real Estate Investment Trusts
- Sector
- EFX Finance
- VTR Real Estate
- Exchange
- EFX Nasdaq
- VTR Nasdaq
- Market Cap
- EFX 30.8B
- VTR 24.7B
- IPO Year
- EFX N/A
- VTR 1998
- Fundamental
- Price
- EFX $268.23
- VTR $60.54
- Analyst Decision
- EFX Strong Buy
- VTR Buy
- Analyst Count
- EFX 17
- VTR 10
- Target Price
- EFX $312.63
- VTR $63.20
- AVG Volume (30 Days)
- EFX 865.8K
- VTR 2.4M
- Earning Date
- EFX 02-06-2025
- VTR 02-12-2025
- Dividend Yield
- EFX 0.58%
- VTR 2.99%
- EPS Growth
- EFX 6.63
- VTR N/A
- EPS
- EFX 4.50
- VTR N/A
- Revenue
- EFX $5,588,200,000.00
- VTR $4,797,115,000.00
- Revenue This Year
- EFX $9.38
- VTR N/A
- Revenue Next Year
- EFX $10.40
- VTR $8.72
- P/E Ratio
- EFX $59.31
- VTR N/A
- Revenue Growth
- EFX 8.79
- VTR 10.05
- 52 Week Low
- EFX $213.02
- VTR $41.45
- 52 Week High
- EFX $309.63
- VTR $67.61
- Technical
- Relative Strength Index (RSI)
- EFX 51.79
- VTR 53.26
- Support Level
- EFX $262.62
- VTR $59.44
- Resistance Level
- EFX $279.73
- VTR $61.46
- Average True Range (ATR)
- EFX 6.22
- VTR 1.22
- MACD
- EFX 0.45
- VTR 0.22
- Stochastic Oscillator
- EFX 38.31
- VTR 59.51
About EFX Equifax Inc.
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.